Lopirazepam | |
---|---|
Molecular structure via molpic based on CDK |
Conformer [] | |
---|---|
Conformer structure via JSmol |
Physical properties [] | |
---|---|
Molecular mass | 322.1 g/mol [1] |
Predicted LogP | 2.7 [1] |
Structural Identifiers [] | |
---|---|
Molecular formula | C14H9Cl2N3O2 [1] |
IUPAC name | 7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydropyrido[3,2-e][1,4]diazepin-2-one [1] |
SMILES | C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2N=C(C=C3)Cl)O)Cl [1] |
InChI | InChI=1S/C14H9Cl2N3O2/c15-8-4-2-1-3-7(8)11-12-9(5-6-10(16)18-12)17-13(20)14(21)19-11/h1-6,14,21H,(H,17,20) [1] |
InChIKey | JEJOFYTVMFVKQA-UHFFFAOYSA-N [1] |
Lopirazepam
Lopirazepam (also known as 2H-Pyrido(3,2-e)-1,4-diazepin-2-one, 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-, Lopirazepamum, 3-hydroxy-5-(o-chlorophenyl)-7-chloro-1,2-dihydro-2H-pyrido(3,2-e)-1,4-diazepin-2-one, 255-974-1, Lopirazepam, (+)-, 12524, 52JHG2TV3G, N6X3ET65NY, 7-chloro-5-(2-chlorophenyl)-3-hydroxy-1,3-dihydro-2h-pyrido[3,2-e][1,4]diazepin-2-one or 7-Chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-pyrido(3,2,-e)-1,4-diazepin-2-one) is a
Chemistry
Stereochemistry []
Lopirazepam is a racemic mixture of the optical stereoisomers
Stereoisomers |
---|
Legal status
- United States: Lopirazepam is a Schedule I under the "Controlled Substances Act (CSA)".
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 68672, Lopirazepam. Accessed July 13, 2025. https://pubchem.ncbi.nlm.nih.gov/compound/68672
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Lopirazepam. UNII: 8PDI6DY6GV. Global Substance Registration System. Accessed July 13, 2025. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/8PDI6DY6GV